This statistic displays the market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, based on revenue and by pharmaceutical company. Over the period of time under consideration, Johnson & Johnson was the leading provider of these pharmaceutical products in Spain in terms of revenue, accounting for over 30 percent of total sales within this segment.
Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
The statistic is available in another language. Switch language.
Print the statistic including description and metadata.
Chart type
Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
IM Farmacias. (December 4, 2018). Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company [Graph]. In Statista. Retrieved December 30, 2024, from https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/
IM Farmacias. "Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company." Chart. December 4, 2018. Statista. Accessed December 30, 2024. https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/
IM Farmacias. (2018). Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company. Statista. Statista Inc.. Accessed: December 30, 2024. https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/
IM Farmacias. "Revenue Market Share of Anti-flu and Anti-cold Drugs Sold in Spain between October 2017 and September 2018, by Pharmaceutical Company." Statista, Statista Inc., 4 Dec 2018, https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/
IM Farmacias, Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company Statista, https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/ (last visited December 30, 2024)
Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company [Graph], IM Farmacias, December 4, 2018. [Online]. Available: https://www.statista.com/statistics/963099/revenue-market-share-of-cold-and-flu-drugs-sold-in-spain-by-company/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.